News | Heart Failure | December 02, 2022

CAROL Act Will Prioritize Research on Heart Valve Disease

Legislation also will create awareness campaign, expand national registry 

Last year, U.S. Congressman Andy Barr (KY-06) introduced this legislation in the House to honor the legacy of his wife, Carol Leavell Barr, who passed away tragically from sudden cardiac death brought on by mitral valve prolapse, an underlying heart condition that causes death in .2% of cases.

Last year, U.S. Congressman Andy Barr (KY-06) introduced this legislation in the House to honor the legacy of his wife, Carol Leavell Barr, who passed away tragically from sudden cardiac death brought on by mitral valve prolapse, an underlying heart condition that causes death in .2% of cases. 

 


December 2, 2022 —  The U.S. Senate today passed the bipartisan Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act, which will prioritize research on valvular heart disease. The bill now heads back to the House of Representatives for a final vote. An earlier version of the bill passed the House unanimously last December. 

Nancy Brown, chief executive of the American Heart Association, a global force for healthier lives for all, issued the following statement: 

“There is still so much we do not know about heart valve disease, which kills approximately 25,000 people each year. The CAROL Act will help advance our understanding and awareness of sudden cardiac death, which took the life of Congressman Andy Barr’s wife, Eleanor “Carol” Leavell Barr, in 2020. 

“The American Heart Association is grateful to Congressman Barr for turning his family tragedy into a compelling movement that will benefit everyone at risk for sudden cardiac death. The CAROL Act will inspire scientists and researchers, create more awareness of valvular heart disease and save lives. This critical legislation will help prevent countless other families from facing the same loss as the Barr family, and we are eager to see the bill finalized and signed into law." 

For more information: www.heart.org 


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now